Training aimed at strengthening Cambodia's capacity to carry out evidence-based policymaking for skills development, ...

Some exploratory associations included lower odds for fracture, incident respiratory disease, and all-cause dementia. Other ...

DiaMedica Therapeutics (NASDAQ:DMAC) executives used the company’s fiscal 2025 earnings call on Monday to highlight clinical progress for its lead asset DM199 and review an improved year-end cash ...

Methylphenidate, the most commonly prescribed treatment for ADHD, is not linked with increased psychosis risk and may even be ...

Completed End-of-Phase 2 meeting with the FDA; Company expects to provide a regulatory update in early 2Q 2026 and remains on track to initiate a Phase 3 study in chronic tetraplegia in mid-2026.

Ad hoc announcement pursuant to Art. 53 LR Phase 2 results show a statistically significant dose-dependent response on total sleep time with clinically meaningful improvements across multiple sleep ...

Allschwil, Switzerland – March 30, 2026 Idorsia Ltd (SIX: IDIA) announces positive top-line results from its Phase 2 ...

With petrol and diesel prices soaring, we're hearing more reports of alleged fuel thefts from petrol stations, farms, trucks ...

More than 60% average improvement in clitoral blood flow observed with both dose-combinations Statistical significance ...

Background Colombia’s prolonged armed conflict has significantly impacted public health. This study constructs a ...

Some papers on so-called alternative medicine (SCAM) are such that I am almost lost for words. Here is the abstract of such an article: Background: Autism Spectrum Disorder is a complex ...

PSNI Chief Constable Jon Boutcher has said he has "significant concerns" over the force's capacity to deal with violence ...